VAD protocol

chemotherapy protocol consisting of above cpds; used in treatment of rhabdomyosarcoma in children

Therapeutics: 1190486
- Drug Therapy: 300623
  - Combination Drug Therapy: 12155
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - VAD protocol: 5
  - Antineoplastic Protocols: 58
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - VAD protocol: 5
- Clinical Protocols
  - Antineoplastic Protocols: 58
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - VAD protocol: 5
Polycyclic Compounds: 7
- Polycyclic Aromatic Hydrocarbons: 2081
  - Naphthacenes
    - Anthracyclines: 9615
      - Daunorubicin: 2659
        Doxorubicin: 36143
        VAD protocol: 5
- Fused-Ring Compounds
  - Steroids: 71426
    - Fluorinated Steroids: 33
      - Dexamethasone: 23674
        VAD protocol: 5
    - Pregnanes: 9
      - Pregnadienes
        Pregnadienetriols
        Dexamethasone: 23674
        VAD protocol: 5
Organic Chemicals: 140
- Hydrocarbons: 1726
  - Cyclic Hydrocarbons: 96
    - Aromatic Hydrocarbons: 295
      - Polycyclic Aromatic Hydrocarbons: 2081
        Naphthacenes
        Anthracyclines: 9615
        Daunorubicin: 2659
        Doxorubicin: 36143
        VAD protocol: 5
Carbohydrates: 22516
- Glycosides: 2186
  - Aminoglycosides: 5203
    - Anthracyclines: 9615
      - Daunorubicin: 2659
        Doxorubicin: 36143
        VAD protocol: 5
Heterocyclic Compounds: 207
- Alkaloids: 5592
  - Indole Alkaloids: 206
    - Secologanin Tryptamine Alkaloids: 84
      - Vinca Alkaloids: 466
        Vincristine: 9350
        VAD protocol: 5
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 205
      - Indole Alkaloids: 206
        Secologanin Tryptamine Alkaloids: 84
        Vinca Alkaloids: 466
        Vincristine: 9350
        VAD protocol: 5
    - Indolizines: 3
      - Indolizidines: 2
        Indole Alkaloids: 206
        Secologanin Tryptamine Alkaloids: 84
        Vinca Alkaloids: 466
        Vincristine: 9350
        VAD protocol: 5

N E Andreeva Selected Research

N E Andreeva Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure